DE

Pneumology

A breath of fresh air – our network of experts

The high quantity and diversity of trials in the area of pneumology, especially in COPD and asthma, result in more and more professionalized study sites. FGK has established a good network with such investigational sites to assure fast recruitment and adequate special measurements as spirometry, ozone challenge or sputum and biomarker analyses.
 

Therapeutic approaches include:

  • Allergic rhinitis
  • Asthma
  • Chronic bronchitis
  • Pneumonia (community acquired / hospital acquired)
  • Chronic obstructive pulmonary disease (COPD)
  • Cystic fibrosis
  • Lung cancer
  • Respiratory syncytial virus (RSV)
  • Ventilator acquired pneumonia
  • Emphysema
  • Pulmonary hypertension

  • Kate Hanrott, EpiEndo Pharmaceuticals

    Director Clinical Operation and Sciences

    “FGK conducted two high quality studies for us, so it was an easy decision to place our next study with them.  All members of the FGK team are a pleasure to work with.  They are quality focused and always happy to go the extra mile.  The project management team are highly experienced and do a fantastic job to lead the study team and ensure high quality delivery. We have been consistently impressed by the data management team, and we have received really positive feedback from our clinical investigator sites about how helpful and thorough the monitors are.  We are really enjoying our partnership with FGK.”

If you’re out of breath regarding the rising tasks in pneumological study design and conduct, get in touch with us.